Other languages Merck & Co., Inc.

Equities

MRK

US58933Y1055

Real-time Estimate Cboe BZX Other stock markets 03:05:19 2024-06-03 pm EDT			5-day change	1st Jan Change
128.3 ^USD	+2.22%		+1.56%	+17.46%

05:32pm	Merck: promising results in melanoma treatment	CF
03:56pm	Merck, Moderna Drug Combo Shows Improved Survival in Skin Cancer Trial	DJ

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Merck : résultat prometteur dans le soin du mélanome	11:32am
Merck, Moderna Drug Combo Shows Improved Survival in Skin Cancer Trial	09:56am
Moderna, Merck Say 3-Year Data for Melanoma Combination Therapy Show Continued Improvement in Recurrence-Free Survival	09:18am
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up	08:00am
Immutep, Merck Collaborate on Trial for Lung Cancer Therapy	04:57am
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival	May. 31
Sector Update: Health Care	May. 31
Declaration of Voting Results by Merck & Co	May. 30
Declaration of Voting Results by Merck & Co	May. 30
Declaration of Voting Results by Merck & Co	May. 30
Declaration of Voting Results by Merck & Co	May. 30
US Equities Markets Close Lower Thursday After Q1 Economic Growth Found to be Slower Than Projected	May. 30
Summit Therapeutics' Ivonescimab Beats Merck's Therapy in Lung Cancer -- Shares Soar	May. 30
Summit Therapeutics Shares Triple After Drug Candidate Data	May. 30
Summit Therapeutics cancer therapy succeeds in late-stage China study	May. 30
Anaveon announces IND approval of ANV600-001 Phase I/II clinical study	May. 30
FDA Grants Priority Review to Merck's Application for KEYTRUDA plus Chemotherapy as First-Line Treatment of Patients with Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma	May. 30
Merck Signs MoU with KAIST to Advance Scientific Collaboration	May. 29
Sector Update: Health Care Stocks Fall Late Afternoon	May. 29
Sector Update: Health Care Stocks Retreat Wednesday Afternoon	May. 29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Merck & Co., Inc.

Equities

MRK

US58933Y1055

Other languages

Filters